Affiliations: [a] Molecular Immunology Group, Tenovus Laboratory, Southampton University Hospitals, Southampton UK | [b] Department of Rheumatology Research, University College and Middlesex School of Medicine, London UK
Correspondence:
[]
Correspondence and reprint requests to: Freda K. Stevenson, PhD, Molecular Immunology Group, Tenovus Laboratory, Southampton University Hospitals, Tremona Road, Southampton S016 6YD, UK.
Abstract: The VH4-21 (V4-34) gene segment, a member of the VH4 family, is expressed early in B-cell maturation and is utilized by approximately 6% of normal adult B lymphocytes. This prevalence indicates an importance of VH4-21 in the B-cell repertoire. The gene also encodes certain autoantibodies being mandatory for pathological IgM anti-red cell antibodies directed against the Iii antigen, and also capable of encoding anti-DNA antibodies. Recognition of I/i antigen or DNA appears to be via two distinct sites on VH, with I/i binding mediated by sequences in the framework region, and DNA binding correlating with the presence of positively charged amino acids in complementarity-determining region 3. However, these positively charged residues appear to suppress the ability of the framework region to interact with Iii, rendering a single sequence monospecific for I/i or DNA. The IgM anti-DNA antibodies also recognize bacterial lipid A, whereas the anti-I/i antibodies do not, indicating that CDR3 may be involved in binding the negatively charged lipid A. Structural similarities between the DNA backbone and lipid A provide a possible explanation for this cross-reactivity. This dual recognition of bacterial antigen and autoantigen provides a potential link between infection and autoimmunity.
Keywords: Anti-DNA, VH4-21, lipid A, cold agglutinins
